by Daniel | Dec 16, 2016 | News |
After more than two years in political limbo, President Barack Obama signed a sweeping bipartisan health care bill Tuesday that will expand medical research, invest in mental health care, battle opioid abuse, and give the U.S. Food and Drug Administration (FDA) more...
by Daniel | Dec 15, 2016 | News |
It’s a drug that millions of Americans take to treat acid reflux and heartburn. Now preliminary research says proton pump inhibitors (PPIs) may increase people’s overall risk of stroke by 21 percent. The study, which followed nearly 250,000 Danish patients for almost...
by Daniel | Dec 15, 2016 | News |
Following a fresh review of studies on the safety of type 2 diabetes medication pioglitazone, the U.S. Food and Drug Administration (FDA) has reaffirmed its warnings that the drug may be linked to an increased risk of bladder cancer. Medicines containing pioglitazone...
by Daniel | Dec 15, 2016 | News |
Fifty-five lawsuits related to diabetes drug Invokana have been consolidated in a New Jersey federal court, according to a Dec. 7 order issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML). The panel approved a request from plaintiffs to centralize the...
by Daniel | Dec 7, 2016 | News |
Johnson & Johnson and its DePuy Orthopaedics unit were ordered to pay more than $1 billion to six plaintiffs after a Texas jury found that the company hid flaws in its Pinnacle hip implants that led to serious complications. The federal jury in Dallas concluded...
Recent Comments